Serum Bilirubin Levels and Mortality Risk: Evaluation of Prognostic Use in a High-Risk Intensive Care Population
Authors:
- Abdullah ŞenAŞAbdullah Şen
- Mahmut YamanMYMahmut Yaman
- Tahir Fırat ZadeoğluTZTahir Fırat Zadeoğlu
- Ercan GündüzEGErcan Gündüz
- Murat OrakMOMurat Orak
- Cahfer GüloğluCGCahfer Güloğlu
- Şilan Göger ÜlgütŞÜŞilan Göger Ülgüt
- Sema BelekSBSema Belek
- Berçem Tugay GünelBGBerçem Tugay Günel
- Mehmet ÜstündağMÜMehmet Üstündağ
Open Access
- 26 March 2025
- journal article
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (1) , 147-153
Abstract
Background: Serum bilirubin serves as a crucial biomarker for liver function and may reflect the severity of systemic inflammatory responses in critically ill patients. This study aims to assess the prognostic significance of serum bilirubin levels in predicting mortality among high-risk patients admitted to the emergency intensive care unit (EICU). Materials and Methods: In this retrospective cohort study, an evaluation was conducted on high-risk patients admitted to the EICU between January 2020 and December 2022. The patients were grouped based on 28-day mortality outcomes. Serum bilirubin levels, along with other clinical and laboratory parameters, were recorded and examined using multivariable logistic regression and receiver operating characteristic (ROC) curve analysis. Results: The most common comorbidities were Chronic Obstructive Pulmonary Disease (COPD) (80.2%) and sepsis (67.2%). Multivariate analyses identified hypertension (OR=4.165, p=0.004), sepsis (OR=8.459, p<0.001), chronic kidney disease (OR=3.910, p=0.009), and total bilirubin levels (OR=1.605, p=0.036) as independent risk factors for mortality. ROC curve analysis demonstrated that a total biliru-bin cutoff value of 1.75 mg/dL provided 86.4% sensitivity and 60.0% specificity in predicting mortality. AUC was calculated to be 0.761, indicating that bilirubin levels possess significant power in distinguis-hing between surviving and died patients. Conclusions: Elevated serum bilirubin levels have been identified as an independent predictor of morta-lity in critically ill patients. This finding suggests that bilirubin levels can serve as a reliable indicator in prognostic evaluations within the EICU setting, thereby contributing to more effective management of the patients' treatment process.Keywords
This publication has 31 references indexed in Scilit:
- Author Correction: Carbon dioxide capture from open air using covalent organic frameworksNature, 2024
- Sex and gender differences in intensive care medicineIntensive Care Medicine, 2023
- Value of Liver Function Tests in CirrhosisJournal of Clinical and Experimental Hepatology, 2022
- Gender Differences in Critical Illness and Critical Care ResearchClinics in Chest Medicine, 2021
- Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS StudyShock, 2021
- Targeting oxidative stress in disease: promise and limitations of antioxidant therapyNature Reviews Drug Discovery, 2021
- Serum bilirubin level correlates with mortality in patients with traumatic brain injuryMedicine, 2020
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Mortality in elderly ICU patients: a cohort studyActa Anaesthesiologica Scandinavica, 2013
- Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’Kidney International, 2013